Market Research Reports and Industry Reports

Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
India pharma rode on the wave of bunched up patent expiries in the US with many Para IV launches in 2012. In addition, it also benefited from the continuing high teen growth of Indian pharma market. With patent expiries in the US dwindling from $30b in 2012 to $10b in 2013 (small molecules), Indian generic companies will now need to focus on complex generics that offer sustainability of earnings. Locally acting drugs and targeted drug delivery products make up for the bulk of complex formulation generics. We have analyzed this space and have provided a fairly comprehensive list of products falling under these categories indicating that topical drugs remains the most near term opportunity for generics. Inhalers offer the most lucrative opportunity, though not before 2016.

Our growth outlook on Indian market continues to remain optimistic with 15-18% growth. This is based on the silent reforms in India that started with implementation of a strict GMP (Good Manufacturing Practices) in 2005, continued with implementation of GLP (Good Laboratories Practices) in 2011 and now the bar coding norms at primary and secondary levels. All these continue to put pressure on the very small manufacturer ultimately leading to industry consolidation something that augurs well for worlds most fragmented pharma market. We do not see any negative impact due to the newly announced National Pharma Pricing Policy (NPPP) due to its emphasis on market price based pricing policy.

Our top pick remains Sun Pharma as it remains the best positioned to tide over the patent cliff with its latest acquisitions, DUSA and URL Pharma. A strong balance sheet further allows it to acquire more such high value targets. We also recommend Natco Pharma for its focus on complex generics like Copaxone, Revlimid and Tamiflu. Besides this, its domestic market strategy targeted at gaining Compulsory License on high value oncology products too remains lucrative.
Key Topics Covered
Branded Liposomal Drugs and Generic Approvals in US
2. Branded Colon Targeted Drugs and Generic Approvals in US
3. Branded Transdermal Drugs and Generic Approvals in US
4. Branded Topical Drugs and Generic Approvals in US
5. Acquisitions in Dermatology Segment
6. Branded Inhalation Drugs and Generic Approvals in US
7. History of Wholesale Price Indices in India
8. Ciplas Inhaler Portfolio Approved Products and Competitive Landscape
9. Ciplas Inhaler Portfolio Pipeline Products and Competitive Landscape

List Of Tables

N/A

List Of Figures

Branded Liposomal Drugs and Generic Approvals in US
2. Branded Colon Targeted Drugs and Generic Approvals in US
3. Branded Transdermal Drugs and Generic Approvals in US
4. Branded Topical Drugs and Generic Approvals in US
5. Acquisitions in Dermatology Segment
6. Branded Inhalation Drugs and Generic Approvals in US
7. History of Wholesale Price Indices in India
8. Ciplas Inhaler Portfolio Approved Products and Competitive Landscape
9. Ciplas Inhaler Portfolio Pipeline Products and Competitive Landscape

Global Pressure Homogenizers Market Research Report 2016

2016 Global Pressure Homogenizers Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Pressure Homogenizers industry, focusing on the main regions

USD 2850View Report

Global Mechanical Homogenizers Market Research Report 2016

2016 Global Mechanical Homogenizers Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Mechanical Homogenizers industry, focusing on the main regions

USD 2850View Report

Global Smart Labels Market Research Report 2016

2016 Global Smart Labels Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Smart Labels industry, focusing on the main regions

USD 2850View Report

Global Pharmaceutical Fermenter Sales Market Report 2016

Notes:Sales, means the sales volume of Pharmaceutical FermenterRevenue, means the sales value of Pharmaceutical FermenterThis report studies sales (consumption) of Pharmaceutical Fermenter in Global market, especially in United States, China,

USD 4000View Report

Memphis Pharmaceutical & Chemicals Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Memphis Pharmaceutical & Chemicals Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Global Pharmaceuticals-Gel Sales Market Report 2016

Notes:Sales, means the sales volume of Pharmaceuticals-GelRevenue, means the sales value of Pharmaceuticals-GelThis report studies sales (consumption) of Pharmaceuticals-Gel in Global market, especially in United States, China, Europe, Japan, focuses

USD 4000View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2500
  • Site Licence    $ 5000
  • Enterprisewide Licence    $ 7500
$ 2500

Reports Details

Published Date : Jan 2013
No. of Pages :50
Country :Global
Category :Healthcare
Publisher :MP Advisors
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment